What is he best known for?
The fields of study he is best known for:
- Alzheimer's disease
- Internal medicine
- Gene
Christopher M. Clark mainly focuses on Alzheimer's disease, Pathology, Dementia, Internal medicine and Frontotemporal dementia.
His study in Alzheimer's disease is interdisciplinary in nature, drawing from both Clinical trial, Central nervous system disease, Degenerative disease, Cerebrospinal fluid and Biomarker.
As a part of the same scientific family, he mostly works in the field of Pathology, focusing on Hippocampal formation and, on occasion, Memory impairment, Hippocampus and Spinal cord.
The study incorporates disciplines such as Positron emission tomography, Pathological and Parkinson's disease in addition to Dementia.
Christopher M. Clark has researched Internal medicine in several fields, including Gastroenterology and Oncology.
His biological study deals with issues like Corticobasal degeneration, which deal with fields such as Neuroscience, Heterozygote advantage, Progressive nonfluent aphasia and Semantic dementia.
His most cited work include:
- Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis (4135 citations)
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. (1523 citations)
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology (789 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Alzheimer's disease, Dementia, Disease, Pathology and Internal medicine.
His Alzheimer's disease research focuses on Degenerative disease and how it connects with Tau protein.
In his research, Clinical psychology is intimately related to Psychiatry, which falls under the overarching field of Dementia.
His Disease research is multidisciplinary, incorporating elements of Clinical trial, Neuroscience, Electroencephalography and Immunology.
His Cerebrospinal fluid, Frontotemporal dementia, Frontotemporal lobar degeneration, Autopsy and Amyloid study are his primary interests in Pathology.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Oncology.
He most often published in these fields:
- Alzheimer's disease (41.30%)
- Dementia (40.49%)
- Disease (37.25%)
What were the highlights of his more recent work (between 2010-2021)?
- Pathology (34.82%)
- Alzheimer's disease (41.30%)
- Dementia (40.49%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Pathology, Alzheimer's disease, Dementia, Internal medicine and Disease.
Many of his research projects under Pathology are closely connected to Context with Context, tying the diverse disciplines of science together.
His Alzheimer's disease research incorporates themes from Neuroimaging, Neuroscience, Semantics and Semantic memory.
His research integrates issues of Temporal cortex, Rating scale, Cognition, Biomarker and Severity of illness in his study of Dementia.
His Internal medicine research includes elements of Endocrinology, Oncology and Cardiology.
His Disease research includes themes of Clinical psychology, Cerebrospinal fluid and Diagnostic biomarker.
Between 2010 and 2021, his most popular works were:
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology (789 citations)
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (504 citations)
- Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease (259 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Alzheimer's disease
- Gene
Christopher M. Clark mostly deals with Alzheimer's disease, Pathology, Dementia, Internal medicine and Positron emission tomography.
His Alzheimer's disease study is concerned with the field of Disease as a whole.
His Pathology research focuses on Frontotemporal dementia in particular.
Specifically, his work in Dementia is concerned with the study of Frontotemporal lobar degeneration.
The Internal medicine study combines topics in areas such as Cognition and Oncology.
In his study, Neuropathology, Cardiology and Nuclear medicine is inextricably linked to Amyloid, which falls within the broad field of Positron emission tomography.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
